Table 4.

Stakeholder involvement methodological quality assessment (AGREE II, domain 2, item 5 stakeholder engagement): on best practice reports with active patient engagement (n=11)

Author, year	Rating criteria				Additional considerations			Overall Stakeholder Involvement Quality Score Item 5 AGREE II (1=poor to 7=exceptional)
	Statement of type of strategy used to capture patients’/public’s views and preferences (eg, participation in the guideline development group, literature review of values and preferences)	Methods by which preferences and views were sought (eg, evidence from literature, surveys, focus groups)	Outcomes/information gathered on patient/public information	Description of how the information gathered was used to inform the guideline development process and/or formation of the recommendations	Is the item well written? Are the descriptions clear and concise?	Is the item content easy to find in the guideline?	Did patients take part in writing recommendations/guidelines?
Ospina et al, 201856	√	√	√	√	√	√		6
NICE, 201631	√	√	√	√	√	√	√	7
Cameron et al, 201635	√	√	√	√	√		√	6
Trillium Health Partners and Mississauga Halton Ccac, 201536	√	√	√	√	√	√	√	7
NICE, 201532	√	√	√	√	√	√	√	7
Coombs et al, 201549	√	√	√	√	√			6
SIGNN, 201034	√	√	√	√	√	√	√	7
Snow et al, 200940	√	√		√	√	√		5
Ball et al, 199738	√	√					√	4
Davies and Hopkins, 199737	√	√		√			√	5
Gresham and Stason, 199539	√	√		√	√	√	√	5
Average score								5.9
SD								1.04
Range								4–7